Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Faculty Opinions recommendation of Structure-Activity Relationship of Aloperine Derivatives as New Anti-Liver Fibrogenic Agents. — Ralf Weiskirchen | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Structure-Activity Relationship of Aloperine Derivatives as New Anti-Liver Fibrogenic Agents.
RW
Shared by
Ralf Weiskirchen
Faculty Opinions recommendation of Structure-Activity Relationship of Aloperine Derivatives as New Anti-Liver Fibrogenic Agents.
Dataset
en
Authors
RW
Ralf Weiskirchen
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2009
Structure−Activity Relationship of New Anti-Hepatitis C Virus Agents: Heterobicycle−Coumarin Conjugates
Johan Neyts
,
De Clercq Erik
,
Raghunath Singha
,
Yung Chang
,
Asish R. Das
,
Subhasish Chakraborty
,
Shih Ching Hong
,
Shwu‐Chen Tsay
,
Ming‐Hua Hsu
,
Jih Ru Hwu
Dataset
Faculty Opinions recommendation of Viral hepatitis and liver cancer.
DOI
10.3410/f.738943157.793580112
Year
Published
—
Language
en
Dataset Details
Link Of The Paper
https://doi.org/10.3410/f.738943157.793580112
Timeline
Created:
June 19, 2026
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Diagnostic autoantibodies for autoimmune liver diseases.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Diagnostic considerations for cholestatic liver disease.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Alberto Mantovani
Discussion(0)
No comments yet. Be the first to comment.